Search results
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga via AOL· 1 day agoAfter topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co...
Merck & Co., Inc. (NYSE:MRK) Just Released Its First-Quarter Earnings: Here's What Analysts Think
Simply Wall St. via Yahoo Finance· 7 days agoMerck & Co., Inc. (NYSE:MRK) just released its quarterly report and things are looking bullish. The...
Here's Why Merck (MRK) is a Strong Momentum Stock
Zacks via Yahoo Finance· 13 hours agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks...
Merck KGaA's Dividend Analysis
GuruFocus.com via Yahoo Finance· 5 days agoMerck KGaA (MKKGY) recently announced a dividend of $0.47 per share, payable on 2024-05-09, with the ex-dividend date set for 2024-04-29. As investors...
Cerevance receives milestone payment under Alzheimer's collaboration with Merck
Seeking Alpha· 1 day agoPrivately held Cerevance receives milestone payment from Merck for Alzheimer's research...
Michael Burgess trades in AbbVie, IBM, iShares ETF, and Merck stocks By Investing.com
Investing.com· 8 hours agoMichael Burgess trades in AbbVie, IBM, iShares ETF, and Merck stocks
Merck & Co., Inc. (NYSE:MRK) Price Target Raised to $143.00
ETF DAILY NEWS· 5 days agoMerck & Co., Inc. (NYSE:MRK – Free Report) had its target price boosted by Truist Financial from $142.00 to $143.00 in a research report released on Friday, Benzinga reports ...
Is Merck Stock Fully Valued At $130?
Forbes· 3 days agoMerck (NYSE: MRK) recently reported its Q1 results, with revenues and earnings exceeding our estimates. The growth was primarily driven by higher sales...
Merck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 days agoMerck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript April 25, 2024 Merck & Co., Inc. beats...
Merck's KEYTRUDA shows survival benefit in gastric cancer trial By Investing.com
Investing.com· 2 days agoMerck & Co., Inc., a leading pharmaceutical company, announced positive results from the Phase 3...